| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/31/2006 | CN1780621A Sulfonamide derivatives as gamma secretase inhibitors. |
| 05/31/2006 | CN1780617A Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 05/31/2006 | CN1778800A Chiral piperazine substrated quinolone carboxylic acid derivative, and preparation and use thereof |
| 05/31/2006 | CN1257902C Method for producing cilostazol |
| 05/31/2006 | CN1257901C Tetrahydroquinoline ketopiperidine compounds and their preparation and use |
| 05/31/2006 | CN1257893C PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | USRE39113 Neuropathic pain; in humans, animals |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053213 Therapeutic heterocycles |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053112 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053108 Indoline compounds |
| 05/30/2006 | US7053107 Antiproliferative agents, angiogenesis inhibitors for treating cancer, eye disorders, diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis; N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide |
| 05/30/2006 | US7053105 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 05/30/2006 | US7053095 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 05/30/2006 | US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 05/30/2006 | US7053091 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053085 EP4 receptor agonist, compositions and methods thereof |
| 05/30/2006 | US7053084 Antagonist for preventing the deposits of amyloid protein, for treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; (2R,3S) N1-[1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-allyl-butanediamide |
| 05/30/2006 | US7053081 Cyclic malonamides as inhibitors of A-β protein production |
| 05/30/2006 | US7053078 Serine protease inhibitors |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7052673 Anticancer, antitumor agents; mixture of metal, drug, peptide and carriers |
| 05/30/2006 | CA2398159C Sulphonylaminocarbonyltriazolinones having substitutents bonded via oxygen |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/30/2006 | CA2195243C Triazole compounds and the use thereof |
| 05/30/2006 | CA2141692C Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
| 05/26/2006 | WO2006055760A1 Triazole compounds that modulate hsp90 activity |
| 05/26/2006 | WO2006055463A2 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/26/2006 | WO2006055462A1 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006054912A1 Aryl(hetaryl)-3-aminomethyl-quinilone-2 derivatives in the form of no-synthetase i and cyclooxygenase-2 nhibitors, methods for the production thereof and compositions based thereon |
| 05/26/2006 | WO2006054700A1 Optical filter |
| 05/26/2006 | WO2006054623A1 Novel pyridonecarboxylic acid derivatives or salts thereof |
| 05/26/2006 | WO2006054560A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | WO2006054314A1 Polymorphic forms of imatinib mesylate |
| 05/26/2006 | WO2006054143A1 Polymorphs of {5-[3-(4,6-difluoro-1h-benzoimidazol-2-yl)-1h-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine |
| 05/26/2006 | WO2006053643A1 N-heterocyclyl phthalic acid diamides as insecticides |
| 05/26/2006 | WO2006053429A1 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| 05/26/2006 | WO2006026760A3 1-amino imidazo-containing compounds and methods |
| 05/26/2006 | WO2006026703A8 Chemical compounds |
| 05/26/2006 | WO2006010079A3 Process for preparing naratriptan hydrochloride |
| 05/26/2006 | WO2005123080A3 Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| 05/26/2006 | WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors |
| 05/26/2006 | CA2588768A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | CA2588766A1 Heterocycle substituted carboxylic acids |
| 05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/26/2006 | CA2588034A1 Pyridonecarboxylic acid derivatives or salts thereof |
| 05/26/2006 | CA2587482A1 N-heterocyclyl phthalic acid diamides as insecticides |
| 05/26/2006 | CA2586612A1 Triazole compounds that modulate hsp90 activity |
| 05/26/2006 | CA2585378A1 Anthranilamide insecticides |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/25/2006 | US20060111573 Resolution of mefloquine with o,o-di-p-aroyltartaric acid |
| 05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111403 Cyano anthranilamide insecticides |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111392 Substituted biaryl-carboxylate derivatives |
| 05/25/2006 | US20060111389 Therapeutic acridone and acridine compounds |
| 05/25/2006 | US20060111377 Heterocyclic derivatives |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111371 Protein tyrosine kinase inhibitors |
| 05/25/2006 | US20060111364 Reversible inhibitors of cysteine proteases S, K, F, L and B; N-[2-(Benzylamino)pyrimidin-4-yl]-N-(cyanomethyl)-L-phenylalaninamide |
| 05/25/2006 | US20060111357 Quinoline compounds for use in mch receptor related disorders |
| 05/25/2006 | US20060111323 Use of polysiloxanes having quaternary ammonium groups as formulation auxiliaries, and compositions comprising them |
| 05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/25/2006 | US20060110638 Electrochromic compounds |
| 05/24/2006 | EP1659129A1 Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658847A2 Indane derivatives as dermal anesthetic agents |
| 05/24/2006 | EP1658503A1 Chemiluminescent compounds |
| 05/24/2006 | EP1658284A1 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/24/2006 | EP1658283A2 Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 05/24/2006 | EP1658280A1 Quinazoline derivatives as angiogenesis inhibitors |
| 05/24/2006 | EP1658270A1 Novel 6-phenylphenantridines |
| 05/24/2006 | EP1658269A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/24/2006 | EP1575935B1 Process for the preparation of sulphinyl derivatives by oxidation of the corresponding sulfides |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | EP1487452B1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl -benzamide for treating seminomas |
| 05/24/2006 | EP1355900B1 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 05/24/2006 | EP1320529B1 Quinoline derivatives as antibacterials |
| 05/24/2006 | EP1254904B1 Novel piperidine compounds and drugs containing the same |
| 05/24/2006 | EP1226129B1 Methods and compositions utilizing quinazolinones |
| 05/24/2006 | EP1212298B1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 05/24/2006 | DE102004055582A1 N-Heterocyclyl-phthalsäurediamide N-heterocyclyl-Phthalamides |
| 05/24/2006 | CN1777600A 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents |
| 05/24/2006 | CN1777599A 5-hydroxyindoles with n-oxide groups and use thereof as a phosphodiesterase 4 inhibitor |
| 05/24/2006 | CN1777598A Polymorphs of s-omeprazole. |
| 05/24/2006 | CN1777597A Indazole having analgesic activity |